Compound details
Dieporeticenin
| Compound ID | CDAMM01303 |
|---|---|
| Common name | Dieporeticenin | IUPAC name | 2-methyl-4-[12-[3-[2-(3-tetradec-3-enyloxiran-2-yl)ethyl]oxiran-2-yl]dodecyl]-2H-furan-5-one |
| Molecular formula | C37H64O4 |
| Retention time | 19.21 |
|---|---|
| Adduct | [M+Na]+ |
| Actual mz | 595.464 | Theoretical mz | 595.469 |
| Error | 8.93 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.8006 |
| Inchi key | NHZOCAXASXRFNX-JZJYNLBNNA-N |
|---|---|
| Smiles | O=C1OC(C=C1CCCCCCCCCCCCC2OC2CCC3OC3CCC=CCCCCCCCCCC)C |
| Superclass | Lipids and lipid-like molecules |
| Class | Fatty Acyls |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T11754 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | O00519 | FAAH |
| T06958 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P06746 | POLB |
| T18664 | DI0163 | General pain disorder | [ICD-11: 8E43] | Q99685 | MGLL |
| T18664 | DI0409 | Tic disorder | [ICD-11: 8A05] | Q99685 | MGLL |